Immunology

New clues in fight against lethal bacteria

New research from The Australian National University (ANU) could lead to better treatment options for a rare but very lethal type of bacterial infection. 

Diseases, Conditions, Syndromes

Novel monoclonal antibody therapy for SARS-CoV-2

An entirely new approach to monoclonal antibody therapy shows that targeting the more genetically stable internal protein of the SARS-CoV-2 virus rather than the surface spike protein can also clear SARS-CoV-2, reports a ...

Diseases, Conditions, Syndromes

How rotavirus causes severe gastrointestinal disease

Rotavirus is a major cause of diarrhea and vomiting, especially in children, that results in approximately 128,000 deaths annually. The virus triggers the disease by infecting enterocyte cells in the small intestine, but ...

Immunology

Researchers unravel the early makings of an exhausted T cell

The immune system struggles to defeat cancer or chronic infections because many of the T cells that leap into action end up "exhausted," rendering them ineffective against disease. That path to exhaustion and what triggers ...

Genetics

Scientists map the human proteome

Twenty years after the release of the human genome, the genetic "blueprint" of human life, an international research team, including the University of British Columbia's Chris Overall, has now mapped the first draft sequence ...

HIV & AIDS

Formula predicts ideal dose of stem cells to cure HIV

Scientists have determined the optimal conditions following a stem cell transplant that could control HIV without the need of an everyday pill, according to a study published today in eLife.

Diseases, Conditions, Syndromes

Protective T cells remain 20 months after COVID

Patients infected with SARS-CoV-2 develop protective immune responses, mediated by virus-specific T cells and antibodies, shortly after the infection. There is concern, however, that immunity does not persist over time, which ...

page 28 from 40